Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 21 2020 - 7:30AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced the Company will present at the 39th
Annual J.P. Morgan Healthcare Conference, which is being held
virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET.
A live webcast of the presentation will be
available in the Events and Presentations section of the Agile
Therapeutics Investor Relations page. The archived webcast will be
available for 30 days.
About Agile Therapeutics, Inc.Agile
Therapeutics is a women's healthcare company dedicated to
fulfilling the unmet health needs of today’s women. Our
product candidates are designed to provide women with contraceptive
options that offer freedom from taking a daily pill, without
committing to a longer-acting method. Our initial product,
Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system
is a non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website
at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Follow Agile on LinkedIn and
Twitter: @AgileTher.
Contact: Matt RileyHead of Investor
Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Sep 2023 to Sep 2024